SEXUAL WELLNESS
PT-141
A melanocortin-targeting peptide that may be prescribed for selected adults with low sexual desire after clinical evaluation.
What it is
PT-141, also called bremelanotide, is a melanocortin receptor agonist used in selected sexual-desire protocols. It acts through central nervous system pathways rather than directly increasing genital blood flow.
How it works
The medication activates melanocortin receptors involved in sexual arousal signaling. A clinician considers blood pressure, cardiovascular history, medications, and the potential cause of low desire before prescribing. Nausea, flushing, and temporary blood-pressure changes are among the issues that require counseling.
Who it is for
- Adults with low sexual desire after a medical and psychosocial assessment
- Patients seeking an option that does not work through the PDE5 pathway
- Patients able to follow dosing and safety instructions
Mechanism in depth
PT-141 (bremelanotide) is a melanocortin receptor agonist. Unlike PDE5 inhibitors, it works centrally in the brain to increase sexual desire and arousal. It is FDA approved as bremelanotide for premenopausal women with hypoactive sexual desire disorder. Use in men is off-label at GPLX under physician supervision.
What outcomes to expect
Onset is typically within thirty to sixty minutes. Effect on arousal and desire varies significantly between patients. Because the mechanism is central rather than vascular, some patients respond who do not respond to PDE5 inhibitors, and vice versa.
Individual response varies. GPLX does not guarantee results. Your physician sets expectations based on your health history and lab findings.
Common side effects
Nausea is the most common side effect, especially at higher doses. Other reported effects include flushing, headache, transient elevated blood pressure, and darkening of the skin at pigmented sites with repeated use.
Monitoring schedule
Baseline cardiovascular and dermatologic review. Follow-up at four to six weeks. Ongoing use is monitored quarterly with attention to blood pressure and any pigmentation changes.
Not appropriate if
Not appropriate if you have uncontrolled hypertension, cardiovascular disease, active melanoma, or if pregnancy is possible without physician review.
Biomarkers reviewed with this treatment
Your physician reviews these markers before and during therapy. Click any marker for a plain-English explanation of what it measures and why it matters.
This treatment is only available after a physician consultation. Book your $149 intake to see if it is appropriate for you.
Book a $149 Consultation